Prelude Therapeutics (PRLD) Total Liabilities (2019 - 2026)
Prelude Therapeutics (PRLD) posted Total Liabilities of $59.5 million for Q1 2026, down 18.19% sequentially from $72.7 million in Q4 2025, and up 56.13% YoY from $38.1 million in Q1 2025.
Prelude Therapeutics (PRLD) Total Liabilities (2019 - 2026) Analysis & Trends
Prelude Therapeutics has reported Total Liabilities for 8 years, with the latest figure at $59.5 million in Q1 2026.
- Quarterly Total Liabilities rose 56.13% year-over-year to $59.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.5 million (up 56.13% YoY) and the FY2025 annual result came in at $72.7 million, up 64.97% from the prior year.
- Total Liabilities retreated to $59.5 million in Q1 2026 per PRLD's latest filing, from $72.7 million in the prior quarter.
- Over five years, Total Liabilities peaked at $72.7 million in Q4 2025 and troughed at $18.2 million in Q2 2022.
- A 5-year average of $35.2 million and a median of $36.4 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities fell 18.72% in 2023, then soared 126.48% in 2024.
- Over 5 years, Total Liabilities stood at $25.1 million in 2022, then soared by 61.89% to $40.6 million in 2023, then increased by 8.58% to $44.1 million in 2024, then soared by 64.97% to $72.7 million in 2025, then decreased by 18.19% to $59.5 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $59.5 million, $72.7 million, and $36.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Prelude Therapeutics | 442.91 Mn | 162.28 Mn | - | 55.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.63 Mn |
| Mar 31, 2026 | 59.46 Mn |
| Dec 31, 2025 | 72.68 Mn |
| Sep 30, 2025 | 36.22 Mn |
| Jun 30, 2025 | 39.08 Mn |
| Mar 31, 2025 | 38.08 Mn |
| Dec 31, 2024 | 44.06 Mn |
| Sep 30, 2024 | 40.79 Mn |
| Jun 30, 2024 | 42.02 Mn |
| Mar 31, 2024 | 36.37 Mn |
| Dec 31, 2023 | 40.58 Mn |
| Sep 30, 2023 | 20.25 Mn |
| Jun 30, 2023 | 18.55 Mn |
| Mar 31, 2023 | 23.02 Mn |
| Dec 31, 2022 | 25.06 Mn |
| Sep 30, 2022 | 24.92 Mn |
| Jun 30, 2022 | 18.21 Mn |
| Mar 31, 2022 | 18.86 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Sep 30, 2021 | 19.98 Mn |